Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02377830
Other study ID # HIREB 14-531
Secondary ID
Status Completed
Phase Phase 2
First received
Last updated
Start date March 2015
Est. completion date December 2018

Study information

Verified date November 2022
Source McMaster University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Background: Patients in the intensive care unit (ICU) are the sickest in hospital, and need advanced life-support. Survivors of critical illness are very weak and disabled. Up to 1 in 4 have severe leg weakness impairing their quality of life for as long as 5 years after ICU discharge. In-bed cycling involves use of special equipment that attaches to a patient's hospital bed, allowing them gentle exercise while in the ICU. Methods: Adult patients admitted to the ICU who need a breathing machine and are expected to survive their ICU stay are eligible. Patients will randomly receive 30 minutes of in-bed cycling each day they are in the ICU or routine physiotherapy, both delivered by specially trained physiotherapists. Outcomes: Feasibility: The investigators will study whether patients can cycle on most days of their ICU stay, whether patients and their families agree to be a part of the study, and whether investigators can systematically assess patients' strength. Relevance: Effective methods of physiotherapy are needed for critically ill patients to minimize muscle weakness, speed recovery, and improve quality of life. This pilot randomized study is the second of several future larger studies about in-bed cycling in the ICU. Our pilot work includes CYCLE Pilot and CYCLE Vanguard. CYCLE Pilot is an external pilot and enrolled 66 patients from 3/2015 to 6/2016. CYCLE Vanguard is an internal pilot and enrolled 47 patients from 11/2016 to 3/2018. CYCLE Vanguard patients will be analyzed in the main CYCLE RCT (NCT03471247).


Recruitment information / eligibility

Status Completed
Enrollment 113
Est. completion date December 2018
Est. primary completion date March 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adults admitted to a medical-surgical ICU within the 1st 4 days of mechanical ventilation (MV) and 1st 7 days of ICU, and - could ambulate independently before hospital admission. Exclusion Criteria: - Acute condition impairing patients' ability to cycle (e.g., leg fracture), - proven or suspected neuromuscular weakness affecting the legs (e.g., stroke or Guillain-Barré syndrome), - unable to follow commands in English pre-ICU, - temporary pacemaker, - expected hospital mortality >90%, - unable to fit the bike, palliative goals of care, or persistent therapy exemptions in the 1st 4 days of MV (e.g., cardiorespiratory instability, active major bleeding)

Study Design


Related Conditions & MeSH terms


Intervention

Device:
In-bed cycle ergometer (Restorative Therapies RT300 Supine)

Other:
Routine physiotherapy
activities to assist with optimizing airway clearance and respiratory function, and, based on the patient's alertness and medical stability, activities to maintain or increase limb range of motion and strength, in- and out of bed mobility, and ambulation

Locations

Country Name City State
Australia Austin Health Melbourne Victoria
Canada Hamilton Health Sciences General ICU Hamilton Ontario
Canada Hamilton Health Sciences Juravinski ICU Hamilton Ontario
Canada St. Joseph's Healthcare Intensive Care Unit Hamilton Ontario
Canada London Health Sciences London Ontario
Canada Ottawa General Hospital Ottawa Ontario
Canada St. Michael's Hospital Toronto Ontario
Canada Toronto General Hospital Toronto Ontario
United States Duke University Medical Center Durham North Carolina

Sponsors (7)

Lead Sponsor Collaborator
McMaster University Canadian Institutes of Health Research (CIHR), Canadian Respiratory Research Network, Hamilton Health Sciences Corporation, Ontario Lung Association, St. Joseph's Healthcare Hamilton, Technology Evaluation in the Elderly Network / Canadian Frailty Network

Countries where clinical trial is conducted

United States,  Australia,  Canada, 

References & Publications (1)

Kho ME, Molloy AJ, Clarke FJ, Reid JC, Herridge MS, Karachi T, Rochwerg B, Fox-Robichaud AE, Seely AJ, Mathur S, Lo V, Burns KE, Ball IM, Pellizzari JR, Tarride JE, Rudkowski JC, Koo K, Heels-Ansdell D, Cook DJ. Multicentre pilot randomised clinical trial — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Katz Activities of Daily Living Scale at ICU and hospital discharge The patient's ability to complete 6 tasks: bathing, dressing, toileting, feeding, continence, and bed mobility. A rater assesses whether the patient is dependent or independent according to pre-specified criteria. From study admission to approximately 12 and 30 days, on average, respectively
Other Euro-QOL 5DL 5 question self-administered, preference-based instrument to measure mobility, self-care, usual activities, pain, and anxiety/ depression, as well as a global assessment of health From study admission to approximately 12 and 30 days, on average, respectively
Primary Patient accrual 2 years
Secondary Cycling protocol violations (% cycling protocol violations) % cycling protocol violations 2 years
Secondary Outcome measure ascertainment (% outcomes measured in hospital) % outcomes measured in hospital 2 years
Secondary Blinded outcome measures at hospital discharge (% outcomes at hospital discharge measured by blinded outcome assessors) % outcomes at hospital discharge measured by blinded outcome assessors 2 years
Secondary Physical Function Test for ICU (PFIT) at ICU awakening, ICU discharge, 3-days post-ICU discharge (CYCLE Vanguard only) and hospital discharge Patients complete 4 activities: arm and leg strength, ability to stand, and step cadence. Scores range from 0 to 10, with higher scores = better function From study admission to approximately 5, 12, 15 and 30 days, on average, respectively
Secondary Muscle strength at ICU awakening, ICU discharge, 3-days post-ICU discharge (CYCLE Vanguard only), and hospital discharge Manual muscle testing using the Medical Research Council (MRC) Scale. The patient exerts a force against the examiner's resistance. Each muscle is assessed on a 6-point MRC scale (0=no contraction; 5=contraction sustained against maximal resistance). From study admission to approximately 5, 12, 15 and 30 days, on average, respectively
Secondary Quadriceps strength at ICU and hospital discharge (Force measured in Kg and in Newtons on a continuous scale) The patient exerts a force against a small strain gauge that fits in the examiner's hand. . From study admission to approximately 12 and 30 days, on average, respectively
Secondary 2 minute walk test at ICU discharge, 3-days post-ICU (CYCLE Vanguard only), and hospital discharge Maximum distance walked in 2 minutes measured in metres on a continuous scale From study admission to approximately 12 and 30 days, on average, respectively
See also
  Status Clinical Trial Phase
Completed NCT03909854 - Pragmatic Investigation of Volume Targeted Ventilation-1 N/A
Recruiting NCT03662438 - HOPE (Home-based Oxygen [Portable] and Exercise) for Patients on Long Term Oxygen Therapy (LTOT) N/A
Recruiting NCT05308719 - Nasal Oxygen Therapy After Cardiac Surgery N/A
Recruiting NCT05535543 - Change in the Phase III Slope of the Volumetric Capnography by Prone Positioning in Acute Respiratory Distress Syndrome
Completed NCT04030208 - Evaluating Safety and Efficacy of Umbulizer in Patients Requiring Intermittent Positive Pressure Ventilation N/A
Recruiting NCT04668313 - COVID-19 Advanced Respiratory Physiology (CARP) Study
Recruiting NCT04542096 - Real Time Evaluation of Dynamic Changes of the Lungs During Respiratory Support of VLBW Neonates Using EIT
Recruiting NCT05883137 - High-flow Nasal Oxygenation for Apnoeic Oxygenation During Intubation of the Critically Ill
Completed NCT04505592 - Tenecteplase in Patients With COVID-19 Phase 2
Completed NCT03943914 - Early Non-invasive Ventilation and High-flow Nasal Oxygen Therapy for Preventing Delayed Respiratory Failure in Hypoxemic Blunt Chest Trauma Patients. N/A
Active, not recruiting NCT03472768 - The Impact of Age-dependent Haptoglobin Deficiency on Plasma Free Hemoglobin Levels During Extracorporeal Membrane Oxygenation Support
Not yet recruiting NCT04538469 - Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
Not yet recruiting NCT02542423 - Endocan Predictive Value in Postcardiac Surgery Acute Respiratory Failure. N/A
Completed NCT02265198 - Relationship of Pulmonary Contusion to Pulmonary Inflammation and Incidence of Acute Respiratory Distress Syndrome N/A
Completed NCT01885442 - TryCYCLE: A Pilot Study of Early In-bed Leg Cycle Ergometry in Mechanically Ventilated Patients N/A
Completed NCT02105298 - Effect of Volume and Type of Fluid on Postoperative Incidence of Respiratory Complications and Outcome (CRC-Study) N/A
Completed NCT01659268 - Performance of Baccalaureate Nursing Students in Insertion of Laryngeal Mask: a Trial in Mannequins N/A
Completed NCT02814994 - Respiratory System Compliance Guided VT in Moderate to Severe ARDS Patients N/A
Completed NCT01249794 - Non Invasive Ventilation After Cardiac Surgery N/A
Completed NCT01204281 - Proportional Assist Ventilation (PAV) in Early Stage of Critically Ill Patients Phase 4